News

BioVitrum and Molecular devices formalized the Distribution agreement on 1st of July 2014.

Molecular Devices is one of the world’s leading providers of high-performance bioanalytical measurement solutions for life science research, pharmaceutical and biotherapeutic development with over 130,000 instrument placements in laboratories around the world that have fueled over 25,000 peer reviewed publications. Included within a broad product portfolio are platforms for high-throughput screening, genomic and cellular analysis, colony selection and microplate detection. These leading-edge products enable scientists to improve productivity and effectiveness, ultimately accelerating research and the discovery of new therapeutics.